Am J Cardiol

1. WANG J
   GLP-1 Receptor Agonist and SGLT2 inhibitor use and Transcatheter Aortic Valve Replacement Outcomes: A Critique and Partial Re-Analysis.
   Am J Cardiol. 2026 Mar 8:S0002-9149(26)00152.
   

   >> Share

   
   
2. PALAKODETI S, Triplett C, Stram D, Stephenson ML, et al
   Valvular Heart Disease during Pregnancy: Outcomes from a Large Integrated Healthcare System.
   Am J Cardiol. 2026 Mar 7:S0002-9149(26)00149.
   

   >> Share

   
   
3. FAHOURY AM, Kamel-Abusalha L, Didier AJ, Wunderly K, et al
   Association of GLP-1 Receptor Agonist and SGLT2 Inhibitor with Cardiovascular Outcomes after Transcatheter Aortic Valve Replacement.
   Am J Cardiol. 2026 Feb 27:S0002-9149(26)00087.
   

   >> Share

   
   

   
   Ann Thorac Surg

4. DEJA MA, Malinowski M, Widenka K, Stozynski N, et al
   Comparison of Repair vs Replacement in Calcific and Rheumatic Mitral Disease.
   Ann Thorac Surg. 2023;116:954-961.
   

   >> Share

   
   
5. KOPRIVANAC M, Sutherland F, Svensson LG, Gillinov M, et al
   Transcervical Robotic Aortic Valve Replacement: A Possible New Frontier in Cardiac Surgery?
   Ann Thorac Surg. 2026 Mar 10:S0003-4975(26)00209.
   

   >> Share

   
   
6. ALABBADI S, Toyoda N, Itagaki S, Iribarne A, et al
   Trends in Utilization and Outcomes of Ross, Transcatheter and Surgical Aortic Valve Replacement in Adults Younger Than 65 Years Old.
   Ann Thorac Surg. 2026 Feb 26:S0003-4975(26)00155.
   

   >> Share

   
   

   
   Catheter Cardiovasc Interv

7. MAZZI W, Azzola Guicciardi N, Beneduce A, Nicola B, et al
   Transcatheter Aortic Valve Implantation in Complex Aortic Pathology: Managing Aortic Regurgitation With Chronic Dissection and Previous Endovascular Repair.
   Catheter Cardiovasc Interv. 2026 Mar 1. doi: 10.1002/ccd.70526.
   

   >> Share

   
   
8. LOEWENSTEIN I, Gitter B, Itach T, Arbel Y, et al
   Long-Term Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli.
   Catheter Cardiovasc Interv. 2026 Mar 1. doi: 10.1002/ccd.70533.
   

   >> Share

   
   
9. POLAT E, Muller L, Schemet L, Friedrich Welz S, et al
   Annular Ellipticity and Sizing Strategy in Transcatheter Aortic Valve Implantation: Independent or Combined Risk Patterns?
   Catheter Cardiovasc Interv. 2026 Mar 1. doi: 10.1002/ccd.70540.
   

   >> Share

   
   
10. AROW Z, Oliva O, Iwata J, Masumoto A, et al
    Effect of Basal Septal Hypertrophy on TAVR Outcomes: Evidence From a Large Cohort Study.
    Catheter Cardiovasc Interv. 2026;107:1267-1276.
    

    >> Share

    
    
11. GALASSO M, Cattaneo G, Casamassima F, Bellamoli M, et al
    Patient-Specific Strategy for Coronary Alignment in TAVI With Evolut FX.
    Catheter Cardiovasc Interv. 2026;107:1112-1119.
    

    >> Share

    
    
12. QADEER A, Fouad M, Khawar M, Khan MH, et al
    Impact of Peri-Procedural Red Blood Cell Transfusion on Clinical Outcomes in Transcatheter Aortic Valve Replacement: A Propensity-Matched Cohort Study.
    Catheter Cardiovasc Interv. 2026 Mar 9. doi: 10.1002/ccd.70554.
    

    >> Share

    
    
13. BAJORAS V, Dabrowski M, Davidavicius G, Cesna S, et al
    Five-Year Clinical and Hemodynamic Evaluation of the Hydra Self-Expanding Transcatheter Heart Valve in Patients With Severe Aortic Stenosis.
    Catheter Cardiovasc Interv. 2026 Mar 2. doi: 10.1002/ccd.70536.
    

    >> Share

    
    

    
    Circ Cardiovasc Imaging

14. MAZZOLA M, De Biase N, Giannini C, Sticchi A, et al
    Hemodynamic and Metabolic-Inflammatory Phenotyping Across the Cardiac Index Spectrum in Moderate and Severe Tricuspid Regurgitation: Prognostic Implications.
    Circ Cardiovasc Imaging. 2026 Mar 6:e019444. doi: 10.1161/CIRCIMAGING.125.019444
    

    >> Share

    
    
15. KIRII Y, Ishiyama M, Kitada K, Takasaki A, et al
    Ruptured Left Sinus of Valsalva Aneurysm With Concomitant Aortic Stenosis Treated by TAVR: CT and TEE Findings.
    Circ Cardiovasc Imaging. 2026 Mar 13:e019498.
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

16. KHERALLAH RY, Zaid S
    Paradox of Elevated Gradients After Valve-in-Valve Transcatheter Aortic Valve Implantation.
    Circ Cardiovasc Interv. 2026 Mar 4:e016577.
    

    >> Share

    
    

    
    Circulation

17. ZHANG X, Hao Y, Han D, Jin X, et al
    PRMT3-Mediated Arginine Methylation Stabilizes PCSK9 to Promote Aortic Valve Calcification.
    Circulation. 2026 Mar 9. doi: 10.1161/CIRCULATIONAHA.125.078830.
    

    >> Share

    
    

    
    Eur Heart J

18. 
    Correction to: Transcatheter edge-to-edge repair vs medical therapy in atrial functional mitral regurgitation: a propensity score-based comparison from the OCEAN-Mitral and REVEAL-AFMR registries.
    Eur Heart J. 2026 Mar 11:ehag190. doi: 10.1093.
    

    >> Share

    
    
19. CREA F
    Valvular heart disease: challenges and opportunity.
    Eur Heart J. 2026;47:1271-1275.
    

    >> Share

    
    
20. PETRONIO AS, Delgado V, Praz F
    The ESC Council on Valvular Heart Disease today and the vision for tomorrow.
    Eur Heart J. 2026 Mar 13:ehag094. doi: 10.1093.
    

    >> Share

    
    
21. LI Q, Fu Z, Song G
    Wearable acoustic cardiography: a novel non-invasive digital sentinel for subclinical leaflet thrombosis after transcatheter aortic valve replacement.
    Eur Heart J. 2026 Mar 13:ehag156. doi: 10.1093.
    

    >> Share

    
    
22. VAN DER ZANDE JA, Ramlakhan KP, Sliwa K, Gnanaraj JP, et al
    Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III.
    Eur Heart J. 2026;47:1318-1335.
    

    >> Share

    
    
23. DOCHERTY KF, Otto CM, McMurray JJV
    Valvular heart failure: evolving pharmacological approaches.
    Eur Heart J. 2026 Jan 13:ehaf1079. doi: 10.1093/eurheartj/ehaf1079.
    

    >> Share

    
    

    
    Eur J Cardiothorac Surg

24. SARIKOUCH S, Boethig D, Avsar M, Ciubotaru A, et al
    20-Year Experience With Decellularized Pulmonary Homografts for Pulmonary Valve Replacement.
    Eur J Cardiothorac Surg. 2026;68:ezag087.
    

    >> Share

    
    

    
    Heart

25. YADAV S, Bansal D, V B, Kumar S, et al
    Rare cardiac outpouching in rheumatic mitral valve disease.
    Heart. 2026;112:409-410.
    

    >> Share

    
    
26. BAAY M, Hosseini Z, Zadgari E, Moayerifar M, et al
    Impact of advanced cardiac damage in severe aortic stenosis on short-term and mid-term mortality and rehospitalisation after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Heart. 2026 Mar 6:heartjnl-2025-326941. doi: 10.1136/heartjnl-2025-326941.
    

    >> Share

    
    

    
    Int J Cardiol

27. MORONI A, Tondi L, Milani V, Pieroni M, et al
    Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis.
    Int J Cardiol. 2023;393:131357.
    

    >> Share

    
    
28. DORIAN D, Scolari FL, Habib M, Brahmbhatt DH, et al
    Association of duration and intensity of exercise with phenotypic expression in hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;392:131253.
    

    >> Share

    
    

    
    J Am Coll Cardiol

29. KAWASHIMA Y, Takeda N, Omori A, Nogimori Y, et al
    Genotype-Guided Risk Stratification of Mitral Valve Surgery in Marfan Syndrome.
    J Am Coll Cardiol. 2026 Mar 4:S0735-1097(26)00238.
    

    >> Share

    
    
30. WANG A, Garcia-Pavia P, Masri A, Merkely B, et al
    Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial.
    J Am Coll Cardiol. 2026;87:1029-1042.
    

    >> Share

    
    
31. NASSIF ME, Garcia-Pavia P, Masri A, Merkely B, et al
    Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2026;87:1046-1058.
    

    >> Share

    
    
32. BJERREGAARD L, Dybro AM, Saaby L, Poulsen SH, et al
    Beta-Blocker (Bisoprolol) vs Calcium-Channel Blocker (Verapamil) in Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Triple-Crossover Physiologic Trial.
    J Am Coll Cardiol. 2026;87:1063-1083.
    

    >> Share

    
    

    
    J Am Soc Echocardiogr

33. PETERS M, Jan MF, Ashraf M, Sanders H, et al
    Myocardial Work in Apical Hypertrophic Cardiomyopathy.
    J Am Soc Echocardiogr. 2023;36:1043-1054.
    

    >> Share

    
    
34. YOGESWARAN V, Otto CM
    Sex-Specific Considerations for Mitral Valve Intervention: An Opportunity for Collaboration.
    J Am Soc Echocardiogr. 2026 Mar 6:S0894-7317(26)00088.
    

    >> Share

    
    
35. YIM J, Tanguturi VK
    A Nudge in the Right Direction: Improving Care Pathways in Severe Aortic Stenosis.
    J Am Soc Echocardiogr. 2026 Mar 3:S0894-7317(26)00086.
    

    >> Share

    
    

    
    J Thorac Cardiovasc Surg

36. DELAY TK, Hawkins RB
    Commentary: Are small aortic valves bad? Definitely! Maybe... It depends?
    J Thorac Cardiovasc Surg. 2026;171:590-591.
    

    >> Share

    
    
37. SALIZZONI S, Yadav R, Nia PS, Adams C, et al
    Micro-invasive, off-pump, trans-ventricular neochordae implantation in recurrent mitral valve regurgitation after open heart surgical repair.
    J Thorac Cardiovasc Surg. 2026 Feb 26:S0022-5223(26)00174.
    

    >> Share

    
    

    
    Pediatr Cardiol

38. AKGUN G, Basar EZ, Cirakoglu AM, Babaoglu K, et al
    Accessory Mitral Valve Tissue: A 15-Year Single-Center Pediatric Experience.
    Pediatr Cardiol. 2026 Mar 7. doi: 10.1007/s00246-025-04143.
    

    >> Share

    
    

    
    PLoS One

39. BAN J, Hu Y, Huang H, Zhang P, et al
    Symptom experiences of patients after cardiac valve surgery: A qualitative study.
    PLoS One. 2026;21:e0342597.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share